Search Results

You are looking at 1 - 7 of 7 items for :

  • "Trachelectomy" x
  • Refine by Access: All x
Clear All
Full access

Nadeem R. Abu-Rustum and Yukio Sonoda

F ertility-sparing radical vaginal or abdominal trachelectomy in select young women with stage I cervical cancer has become an acceptable alternative to radical hysterectomy in many gynecologic oncology practices worldwide. 1 – 8 The abdominal

Full access

Heidi J. Gray

past 16 years . Gynecol Oncol 2001 ; 81 : 133 – 137 . 23. Dargent D Martin X Sacchetoni A Mathevet P . Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients . Cancer 2000 ; 88

Full access

Wui-Jin Koh, Benjamin E. Greer, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, Kathleen R. Cho, Christina Chu, David Cohn, Marta Ann Crispens, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Frederick, David K. Gaffney, Ernest Han, Warner K. Huh, John R. Lurain III, David Mutch, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Nelson Teng, Todd Tillmanns, Fidel A. Valea, Catheryn M. Yashar, Nicole R. McMillian, and Jillian L. Scavone

and conservative treatment with conization seems to be safe in individuals with no evidence of LVSI. 48 For stage IA2 and IB1 cervical cancers with lesions that are 2 cm or less in diameter, radical trachelectomy provides a fertility-sparing option

Full access

Wui-Jin Koh, Nadeem R. Abu-Rustum, Sarah Bean, Kristin Bradley, Susana M. Campos, Kathleen R. Cho, Hye Sook Chon, Christina Chu, Rachel Clark, David Cohn, Marta Ann Crispens, Shari Damast, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Frederick, David K. Gaffney, Ernest Han, Warner K. Huh, John R. Lurain III, Andrea Mariani, David Mutch, Christa Nagel, Larissa Nekhlyudov, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Todd Tillmanns, Stefanie Ueda, Emily Wyse, Catheryn M. Yashar, Nicole R. McMillian, and Jillian L. Scavone

be added as clinically indicated. Select patients with stage IA2 or IB1 cervical cancer, especially for those with tumors of less than 2 cm in diameter, may be eligible for conservative surgery. 46 , 47 Radical trachelectomy may offer a reasonable

Full access

Wui-Jin Koh, Benjamin E. Greer, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, John Chan, Kathleen R. Cho, David Cohn, Marta Ann Crispens, Nefertiti DuPont, Patricia J. Eifel, David K. Gaffney, Robert L. Giuntoli II, Ernest Han, Warner K. Huh, John R. Lurain III, Lainie Martin, Mark A. Morgan, David Mutch, Steven W. Remmenga, R. Kevin Reynolds, William Small Jr, Nelson Teng, Todd Tillmanns, Fidel A. Valea, Nicole R. McMillian, and Miranda Hughes

patients with negative margins after cone biopsy, observation is an option for select patients without LVSI if they desire fertility preservation. For patients with positive margins after cone biopsy, options include either a radical trachelectomy or a

Full access

Benjamin E. Greer, Wui-Jin Koh, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, John Chan, Kathleen R. Cho, Larry Copeland, Marta Ann Crispens, Nefertiti DuPont, Patricia J. Eifel, David K. Gaffney, Warner K. Huh, Daniel S. Kapp, John R. Lurain III, Lainie Martin, Mark A. Morgan, Robert J. Morgan Jr., David Mutch, Steven W. Remmenga, R. Kevin Reynolds, William Small Jr., Nelson Teng, and Fidel A. Valea

, trachelectomy and pelvic lymph node dissection can be considered with (or without) para-aortic lymph node sampling for stage IA cervical cancer (see page 1391). 64 – 67 Stage IA2 Disease: Stage IA2 tumors can be treated with radical hysterectomy or radical

Full access

NCCN Guidelines Insights: Cervical Cancer, Version 1.2020

Featured Updates to the NCCN Guidelines

Nadeem R. Abu-Rustum, Catheryn M. Yashar, Sarah Bean, Kristin Bradley, Susana M. Campos, Hye Sook Chon, Christina Chu, David Cohn, Marta Ann Crispens, Shari Damast, Christine M. Fisher, Peter Frederick, David K. Gaffney, Robert Giuntoli II, Ernest Han, Warner K. Huh, John R. Lurain III, Andrea Mariani, David Mutch, Christa Nagel, Larissa Nekhlyudov, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Rachel Sisodia, Todd Tillmanns, Stefanie Ueda, Renata Urban, Emily Wyse, Nicole R. McMillian, and Angela D. Motter

-sparing conservative treatment (ie, cone biopsy, trachelectomy), because these patients generally have low risk of metastases and recurrence. Patients with IA2 cervical cancer (DOI >3 mm) may also be candidates for these procedures, but also typically undergo